Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice.

Liang Y, Besch-Williford C, Cook MT, Belenchia A, Brekken RA, Hyder SM.

Breast Cancer (Dove Med Press). 2019 Jul 31;11:249-259. doi: 10.2147/BCTT.S208706. eCollection 2019.

2.

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts.

Liang Y, Mafuvadze B, Besch-Williford C, Hyder SM.

Breast Cancer (Dove Med Press). 2018 Mar 22;10:53-67. doi: 10.2147/BCTT.S156285. eCollection 2018.

3.

A Naturally Transmitted Epitheliotropic Polyomavirus Pathogenic in Immunodeficient Rats: Characterization, Transmission, and Preliminary Epidemiologic Studies.

Besch-Williford C, Pesavento P, Hamilton S, Bauer B, Kapusinszky B, Phan T, Delwart E, Livingston R, Cushing S, Watanabe R, Levin S, Berger D, Myles M.

Toxicol Pathol. 2017 Jul;45(5):593-603. doi: 10.1177/0192623317723541. Epub 2017 Aug 7.

PMID:
28782456
4.

Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells.

Cook MT, Liang Y, Besch-Williford C, Hyder SM.

Breast Cancer (Dove Med Press). 2016 Dec 23;9:9-19. doi: 10.2147/BCTT.S124860. eCollection 2017.

5.

Influence of Rack Design and Disease Prevalence on Detection of Rodent Pathogens in Exhaust Debris Samples from Individually Ventilated Caging Systems.

Bauer BA, Besch-Williford C, Livingston RS, Crim MJ, Riley LK, Myles MH.

J Am Assoc Lab Anim Sci. 2016 Nov;55(6):782-788.

6.

Bordetella pseudohinzii as a Confounding Organism in Murine Models of Pulmonary Disease.

Clark SE, Purcell JE, Sammani S, Steffen EK, Crim MJ, Livingston RS, Besch-Williford C, Fortman JD.

Comp Med. 2016;66(5):361-366.

7.

Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.

Cook MT, Mafuvadze B, Besch-Williford C, Ellersieck MR, Goyette S, Hyder SM.

Oncol Rep. 2016 Feb;35(2):825-32. doi: 10.3892/or.2015.4431. Epub 2015 Nov 17.

PMID:
26719029
8.

Delayed and Aberrant Presentation of VX2 Carcinoma in a Rabbit Model of Hepatic Neoplasia.

Hansen SA, Fink MK, Upendran A, Besch-Williford CL, Livingston RS, Amos-Landgraf JM, Lattimer JC, Kannan R.

Comp Med. 2015 Oct;65(5):424-8.

9.

Endocrine-Disrupting Activity of Hydraulic Fracturing Chemicals and Adverse Health Outcomes After Prenatal Exposure in Male Mice.

Kassotis CD, Klemp KC, Vu DC, Lin CH, Meng CX, Besch-Williford CL, Pinatti L, Zoeller RT, Drobnis EZ, Balise VD, Isiguzo CJ, Williams MA, Tillitt DE, Nagel SC.

Endocrinology. 2015 Dec;156(12):4458-73. doi: 10.1210/en.2015-1375. Epub 2015 Oct 14.

PMID:
26465197
10.

Inhibition of Gli/hedgehog signaling in prostate cancer cells by "cancer bush" Sutherlandia frutescens extract.

Lin H, Jackson GA, Lu Y, Drenkhahn SK, Brownstein KJ, Starkey NJ, Lamberson WR, Fritsche KL, Mossine VV, Besch-Williford CL, Folk WR, Zhang Y, Lubahn DB.

Cell Biol Int. 2016 Feb;40(2):131-42. doi: 10.1002/cbin.10544. Epub 2015 Oct 6.

11.

Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.

Cook MT, Liang Y, Besch-Williford C, Goyette S, Mafuvadze B, Hyder SM.

Springerplus. 2015 Aug 22;4:444. doi: 10.1186/s40064-015-1242-x. eCollection 2015.

12.

Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071.

Liang Y, Besch-Williford C, Aebi JD, Mafuvadze B, Cook MT, Zou X, Hyder SM.

Breast Cancer Res Treat. 2014 Jul;146(1):51-62. doi: 10.1007/s10549-014-2996-5. Epub 2014 May 31.

PMID:
24878988
13.

Conditional knockout of the RNA-binding protein HuR in CD4⁺ T cells reveals a gene dosage effect on cytokine production.

Gubin MM, Techasintana P, Magee JD, Dahm GM, Calaluce R, Martindale JL, Whitney MS, Franklin CL, Besch-Williford C, Hollingsworth JW, Abdelmohsen K, Gorospe M, Atasoy U.

Mol Med. 2014 Mar 20;20:93-108. doi: 10.2119/molmed.2013.00127.

14.

Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.

Mafuvadze B, Cook M, Xu Z, Besch-Williford CL, Hyder SM.

Nutr Cancer. 2013;65(8):1184-91. doi: 10.1080/01635581.2013.833637. Epub 2013 Oct 15.

PMID:
24127693
15.

Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation.

Angle BM, Do RP, Ponzi D, Stahlhut RW, Drury BE, Nagel SC, Welshons WV, Besch-Williford CL, Palanza P, Parmigiani S, vom Saal FS, Taylor JA.

Reprod Toxicol. 2013 Dec;42:256-68. doi: 10.1016/j.reprotox.2013.07.017. Epub 2013 Jul 25.

16.

Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases.

Cai QY, Yu P, Besch-Williford C, Smith CJ, Sieckman GL, Hoffman TJ, Ma L.

Prostate. 2013 Jun;73(8):842-54. doi: 10.1002/pros.22630. Epub 2012 Dec 31.

PMID:
23280511
17.

The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.

Carroll CE, Liang Y, Benakanakere I, Besch-Williford C, Hyder SM.

Int J Oncol. 2013 Jan;42(1):179-87. doi: 10.3892/ijo.2012.1675. Epub 2012 Oct 24.

18.

Creation and preliminary characterization of a Tp53 knockout rat.

McCoy A, Besch-Williford CL, Franklin CL, Weinstein EJ, Cui X.

Dis Model Mech. 2013 Jan;6(1):269-78. doi: 10.1242/dmm.009704. Epub 2012 Aug 23.

19.

Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide.

Newton-Northup JR, Dickerson MT, Ma L, Besch-Williford CL, Deutscher SL.

Clin Exp Metastasis. 2013 Feb;30(2):119-32. doi: 10.1007/s10585-012-9516-y. Epub 2012 Aug 1.

PMID:
22851004
20.

Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP mice.

Slusarz A, Jackson GA, Day JK, Shenouda NS, Bogener JL, Browning JD, Fritsche KL, MacDonald RS, Besch-Williford CL, Lubahn DB.

Endocrinology. 2012 Sep;153(9):4160-70. doi: 10.1210/en.2012-1030. Epub 2012 Jun 29.

21.

Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.

Mafuvadze B, Liang Y, Besch-Williford C, Zhang X, Hyder SM.

Horm Cancer. 2012 Aug;3(4):160-71. doi: 10.1007/s12672-012-0114-x. Epub 2012 May 9.

PMID:
22569706
22.

Differential expression of FGF family members in a progestin-dependent BT-474 human breast cancer xenograft model.

López Pérez FR, Liang Y, Besch-Williford CL, Mafuvadze B, Hyder SM.

Histol Histopathol. 2012 Mar;27(3):337-45. doi: 10.14670/HH-27.337.

PMID:
22237711
23.

Conditional deletion of calcium-modulating cyclophilin ligand causes deafness in mice.

Bryda EC, Johnson NT, Ohlemiller KK, Besch-Williford CL, Moore E, Bram RJ.

Mamm Genome. 2012 Apr;23(3-4):270-6. doi: 10.1007/s00335-011-9381-z. Epub 2011 Dec 15.

PMID:
22170629
24.

Deficient degradation of homotrimeric type I collagen, α1(I)3 glomerulopathy in oim mice.

Roberts-Pilgrim AM, Makareeva E, Myles MH, Besch-Williford CL, Brodeur AC, Walker AL, Leikin S, Franklin CL, Phillips CL.

Mol Genet Metab. 2011 Nov;104(3):373-82. doi: 10.1016/j.ymgme.2011.07.025. Epub 2011 Jul 31.

25.

In vivo tropisms and kinetics of rat theilovirus infection in immunocompetent and immunodeficient rats.

Drake MT, Besch-Williford C, Myles MH, Davis JW, Livingston RS.

Virus Res. 2011 Sep;160(1-2):374-80. doi: 10.1016/j.virusres.2011.07.014. Epub 2011 Jul 26.

26.

Pneumocystis carinii infection causes lung lesions historically attributed to rat respiratory virus.

Livingston RS, Besch-Williford CL, Myles MH, Franklin CL, Crim MJ, Riley LK.

Comp Med. 2011 Feb;61(1):45-59.

27.

Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.

Mafuvadze B, Benakanakere I, López Pérez FR, Besch-Williford C, Ellersieck MR, Hyder SM.

Cancer Prev Res (Phila). 2011 Aug;4(8):1316-24. doi: 10.1158/1940-6207.CAPR-10-0382. Epub 2011 Apr 19.

28.

Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague.

Eisele NA, Lee-Lewis H, Besch-Williford C, Brown CR, Anderson DM.

Am J Pathol. 2011 Mar;178(3):1190-200. doi: 10.1016/j.ajpath.2010.11.067.

29.

Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.

Benakanakere I, Besch-Williford C, Carroll CE, Hyder SM.

Cancer Prev Res (Phila). 2010 Sep;3(9):1157-67. doi: 10.1158/1940-6207.CAPR-10-0064. Epub 2010 Aug 10.

30.

Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.

Liang Y, Benakanakere I, Besch-Williford C, Hyder RS, Ellersieck MR, Hyder SM.

Menopause. 2010 Sep-Oct;17(5):1040-7. doi: 10.1097/gme.0b013e3181d3dd0c.

31.

Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer.

Slusarz A, Shenouda NS, Sakla MS, Drenkhahn SK, Narula AS, MacDonald RS, Besch-Williford CL, Lubahn DB.

Cancer Res. 2010 Apr 15;70(8):3382-90. doi: 10.1158/0008-5472.CAN-09-3012.

32.

Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors.

Liang Y, Besch-Williford C, Benakanakere I, Thorpe PE, Hyder SM.

Breast Cancer Res Treat. 2011 Jan;125(2):407-20. doi: 10.1007/s10549-010-0851-x. Epub 2010 Mar 27.

33.

The protective effect of amifostine on ultraviolet B-exposed xeroderma pigmentosum mice.

Henry S, Christiansen D, Kazmier F, Besch-Williford C, Concannon M.

Ecancermedicalscience. 2010;4:176. doi: 10.3332/ecancer.2010.176. Epub 2010 Sep 22.

34.

PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein.

Liang Y, Besch-Williford C, Hyder SM.

Int J Oncol. 2009 Nov;35(5):1015-23.

PMID:
19787255
35.

Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.

Carroll CE, Benakanakere I, Besch-Williford C, Ellersieck MR, Hyder SM.

Menopause. 2010 Jan-Feb;17(1):178-84. doi: 10.1097/gme.0b013e3181afcce5.

36.

The Xpc gene markedly affects cell survival in mouse bone marrow.

Fischer JL, Kumar MA, Day TW, Hardy TM, Hamilton S, Besch-Williford C, Safa AR, Pollok KE, Smith ML.

Mutagenesis. 2009 Jul;24(4):309-16. doi: 10.1093/mutage/gep011. Epub 2009 Apr 16.

37.

Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.

Benakanakere I, Besch-Williford C, Ellersieck MR, Hyder SM.

Endocr Relat Cancer. 2009 Mar;16(1):85-98. doi: 10.1677/ERC-08-0069. Epub 2008 Dec 15.

PMID:
19075036
38.

Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model.

Ruhlen RL, Willbrand DM, Besch-Williford CL, Ma L, Shull JD, Sauter ER.

Breast Cancer Res Treat. 2009 Oct;117(3):517-24. doi: 10.1007/s10549-008-0169-0. Epub 2008 Sep 9.

39.

Tissue engineering by self-assembly of cells printed into topologically defined structures.

Jakab K, Norotte C, Damon B, Marga F, Neagu A, Besch-Williford CL, Kachurin A, Church KH, Park H, Mironov V, Markwald R, Vunjak-Novakovic G, Forgacs G.

Tissue Eng Part A. 2008 Mar;14(3):413-21. doi: 10.1089/tea.2007.0173.

PMID:
18333793
40.

Anoikis effector Bit1 negatively regulates Erk activity.

Kairouz-Wahbe R, Biliran H, Luo X, Khor I, Wankell M, Besch-Williford C, Pascual J, Oshima R, Ruoslahti E.

Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1528-32. doi: 10.1073/pnas.0711357105. Epub 2008 Jan 24.

41.

Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.

Liang Y, Besch-Williford C, Brekken RA, Hyder SM.

Cancer Res. 2007 Oct 15;67(20):9929-36.

42.

Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.

Liang Y, Besch-Williford C, Benakanakere I, Hyder SM.

Int J Oncol. 2007 Oct;31(4):777-84.

PMID:
17786308
43.

Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo.

Shenouda NS, Sakla MS, Newton LG, Besch-Williford C, Greenberg NM, MacDonald RS, Lubahn DB.

Endocrine. 2007 Feb;31(1):72-81.

PMID:
17709901
44.

Morphologic and histologic comparisons between in vivo and nuclear transfer derived porcine embryos.

Martin L, Besch-Williford C, Lai L, Cheong HT, Im GS, Park KW, Murphy C, Hao Y, Ellersieck MR, Keisler DH, Schatten H, Green JA, Prather RS.

Mol Reprod Dev. 2007 Aug;74(8):952-60.

45.

Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.

Benakanakere I, Besch-Williford C, Schnell J, Brandt S, Ellersieck MR, Molinolo A, Hyder SM.

Clin Cancer Res. 2006 Jul 1;12(13):4062-71.

46.

1,3-dinitrobenzene toxicity in the least shrew, Cryptotis parva.

Mock OB, Casteel SW, Darmani NA, Shaddy JH, Besch-Williford C, Towns LC.

Environ Toxicol Chem. 2005 Oct;24(10):2519-25.

PMID:
16268153
47.

Haematoloechus sp. infection in wild-caught northern leopard frogs (Rana pipiens).

Hsu C, Carter DB, Williams D, Besch-Williford C.

Contemp Top Lab Anim Sci. 2004 Nov;43(6):14-6; quiz 58.

PMID:
15636549
48.
49.

Vitamin A toxicity and vitamin E deficiency in a rabbit colony.

St Claire MB, Kennett MJ, Besch-Williford CL.

Contemp Top Lab Anim Sci. 2004 Jul;43(4):26-30.

PMID:
15264766
50.

Characterization of a novel parainfluenza virus, caviid parainfluenza virus 3, from laboratory guinea pigs (Cavia porcellus).

Simmons JH, Purdy GA, Franklin CL, Trottier P, Churchill AE, Russell RJ, Besch-Williford CL, Riley LK.

Comp Med. 2002 Dec;52(6):548-54.

PMID:
12540169

Supplemental Content

Loading ...
Support Center